|
|
Volumn 3, Issue 1, 2005, Pages 19-24
|
|
Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
PARATHYROID HORMONE[1-34];
RECOMBINANT PROTEIN;
ANIMAL;
BONE;
BONE DENSITY;
BONE DEVELOPMENT;
BONE REMODELING;
DRUG EFFECT;
FEMALE;
FRACTURE;
HUMAN;
POROSITY;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
RISK FACTOR;
STIMULATION;
TIME;
ANIMALS;
BIOLOGICAL MARKERS;
BONE AND BONES;
BONE DENSITY;
BONE REMODELING;
FEMALE;
FRACTURES, BONE;
HUMANS;
OSTEOGENESIS;
OSTEOPOROSIS, POSTMENOPAUSAL;
POROSITY;
RECOMBINANT PROTEINS;
RISK FACTORS;
STIMULATION, CHEMICAL;
TERIPARATIDE;
TIME FACTORS;
|
|
EID: 26044477835
PISSN: 15441873
EISSN: None
Source Type: Journal
DOI: 10.1007/s11914-005-0023-9 Document Type: Review |
|
Times cited : (39)
|
|
References (43)
|
